Article By:
Zacks Investment Research
Tuesday, June 2, 2015 3:32 PM EDT
MDT's fourth-quarter fiscal 2015 financial results also marked the first quarter of Medtronic-Covidien’s consolidated performance following the completion of the long-awaited $42.9 billion takeover of Covidien on Jan 26. Stock has held steady today.